tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:VX1 Stock Latest News

Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
The FlyVertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
3d ago
AMGN
REGN
Amgen price target raised to $390 from $375 at Wells Fargo
PremiumThe Fly
Amgen price target raised to $390 from $375 at Wells Fargo
3d ago
AMGN
REGN
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
4d ago
CF
EXR
Maxim upgrades Vertex to Buy on diversification of revenue
PremiumThe Fly
Maxim upgrades Vertex to Buy on diversification of revenue
4d ago
VRTX
Vertex Pharmaceuticals upgraded to Buy from Hold at Maxim
PremiumThe Fly
Vertex Pharmaceuticals upgraded to Buy from Hold at Maxim
4d ago
VRTX
Insmed assumed with a Buy at Jefferies
PremiumThe FlyInsmed assumed with a Buy at Jefferies
6d ago
INSM
VRTX
Vertex Pharmaceuticals price target raised to $525 from $490 at Truist
Premium
The Fly
Vertex Pharmaceuticals price target raised to $525 from $490 at Truist
11d ago
VRTX
Vera Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research
Premium
The Fly
Vera Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research
11d ago
VERA
VRTX
Early notable gainers among liquid option names on March 10th
PremiumThe Fly
Early notable gainers among liquid option names on March 10th
12d ago
MU
GLW
Video: Kohl’s slips after Q4 earnings report
PremiumThe Fly
Video: Kohl’s slips after Q4 earnings report
12d ago
HPE
KSS
Morning Movers: BioNTech sinks following departure of founders, Q4 results
PremiumThe Fly
Morning Movers: BioNTech sinks following departure of founders, Q4 results
12d ago
BG
HPE
Vertex poses ‘no threat’ to Vera Therapeutics’ atacicept, says BofA
PremiumThe Fly
Vertex poses ‘no threat’ to Vera Therapeutics’ atacicept, says BofA
12d ago
VERA
VRTX
Vertex Pharmaceuticals price target raised to $600 from $540 at Oppenheimer
PremiumThe FlyVertex Pharmaceuticals price target raised to $600 from $540 at Oppenheimer
12d ago
VRTX
Vertex Pharmaceuticals: RAINIER Data Strengthen Best-in-Class IgAN Potential and Support Upside Beyond Durable CF Cash Flows
Premium
Ratings
Vertex Pharmaceuticals: RAINIER Data Strengthen Best-in-Class IgAN Potential and Support Upside Beyond Durable CF Cash Flows
12d ago
VRTX
Vertex Pharmaceuticals price target raised to $641 from $591 at H.C. Wainwright
Premium
The Fly
Vertex Pharmaceuticals price target raised to $641 from $591 at H.C. Wainwright
12d ago
VRTX
Vertex Pharmaceuticals price target raised to $598 from $571 at BofA
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $598 from $571 at BofA
12d ago
VRTX
Compelling Buy Thesis on Vertex: Strong IgAN Pivotal Data, Clean Safety, and Robust Peak Sales Potential Support Large-Cap Biotech Upside
PremiumRatings
Compelling Buy Thesis on Vertex: Strong IgAN Pivotal Data, Clean Safety, and Robust Peak Sales Potential Support Large-Cap Biotech Upside
12d ago
VRTX
Vertex Pharmaceuticals price target raised to $596 from $570 at Morgan Stanley
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $596 from $570 at Morgan Stanley
12d ago
VRTX
Vertex Pharmaceuticals price target raised to $585 from $575 at Citi
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $585 from $575 at Citi
12d ago
VRTX
Vertex Pharmaceuticals initiated with a Buy at Jefferies
PremiumThe FlyVertex Pharmaceuticals initiated with a Buy at Jefferies
12d ago
VRTX
Vertex Pharmaceuticals: Upgraded Confidence in Povetacicept Drives Strengthened Buy Thesis After Robust Phase III RAINIER Data in IgA Nephropathy
Premium
Ratings
Vertex Pharmaceuticals: Upgraded Confidence in Povetacicept Drives Strengthened Buy Thesis After Robust Phase III RAINIER Data in IgA Nephropathy
12d ago
VRTX
Vertex Pharmaceuticals up 7% at $492 after positive Povetacicept results
Premium
The Fly
Vertex Pharmaceuticals up 7% at $492 after positive Povetacicept results
12d ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >